MyndTec Inc. Completes Third Tranche of Private Placement, Raising Over $415K

MyndTec, Inc. ( (TSE:MYTC) ) has shared an update.

MyndTec Inc. has successfully completed the third tranche of its non-brokered private placement, raising $137,314.60 through the issuance of 686,573 units at $0.20 per unit. The funds will be used for general corporate purposes, including the development of machine learning models and settling outstanding debts. The completion of this tranche brings the total proceeds from the offering to $415,266.40. The transaction includes participation from related parties, constituting a ‘related party transaction’ under MI 61-101, but it is exempt from certain requirements due to the company’s market status.

Spark’s Take on TSE:MYTC Stock

According to Spark, TipRanks’ AI Analyst, TSE:MYTC is a Underperform.

MyndTec, Inc. faces significant financial challenges, with substantial risks due to negative equity and persistent losses, which weigh heavily on its overall score. Despite some positive momentum from a recent private placement initiative, the technical indicators suggest a bearish trend, and the absence of key valuation metrics further limits investor appeal. Collectively, these factors contribute to a low overall score, indicating caution for potential investors.

To see Spark’s full report on TSE:MYTC stock, click here.

More about MyndTec, Inc.

MyndTec Inc. is a CSE-listed medical technology company that specializes in neurostimulation to aid in the recovery and treatment of individuals with central nervous system disorders, such as Parkinson’s disease, Alzheimer’s disease, and stroke. The company has developed the MyndMove™ system, a non-invasive intervention that utilizes functional electrical stimulation to promote neuroplasticity and help patients regain voluntary movement and independence.

Average Trading Volume: 7,500

Technical Sentiment Signal: Sell

For a thorough assessment of MYTC stock, go to TipRanks’ Stock Analysis page.